The pharmaceutical industry has withdrawn from the ‘antibiotic space.’ Is it time for research universities to step in?

This is the inescapable conclusion of Michael Kinch’s adventures in data mining

After 12 years of hosting the annual Ion Channel Retreat in Vancouver, Aurora Biomed is expanding its global reach to include a second retreat in Guangzhou, China.

Rigaku Raman Technologies, a leading pioneer of handheld and portable Raman spectrometers, will be showcasing its new generation handheld Raman analyzer for raw material identification (RMID) in booth 1C82 at CPhI Worldwide 2014 (7-9th October 2014. Paris Nord Villepinte, France). Progeny™ (http://www.rigakuprogeny.com) delivers improved performance, ease of use and confidence to ensure the industry’s most accurate and comprehensive range of material identification in a handheld form.

Thermo Fisher Scientific has developed an efficient ion chromatography (IC) method with on-line sample cleanup for the rapid and sensitive determination of p-toluenesulfonic acid in water-insoluble drugs.

An analysis of patented university inventions licensed to biotechnology firms has revealed early bottlenecks on the path to commercialization. To open these roadblocks, the researchers suggest that better communication of basic research results during the discovery stage could lead to faster commercialization down the road.

Creation of startup follows Wyss mission of ‘benchtop to marketplace.’

Malvern Instruments Ltd (Malvern, UK) has today (July 25) announced that it has completed the acquisition of MicroCal from GE Healthcare Life Sciences and has also purchased the Archimedes particle characterization system from Affinity Biosensors LLC (Santa Barbara, CA). Both of these developments extend Malvern’s portfolio of analytical solutions for the rapidly advancing biopharmaceutical industry.

Green-chemistry researchers at McGill University have discovered a way to use water as a solvent in one of the reactions most widely used to synthesize chemical products and pharmaceuticals.

Scientists at Thermo Fisher Scientific and BioAnalytix, Inc., of Cambridge, MA, are combining their expertise to develop advanced analytical profiling platforms and applications to characterize biologic and biosimilar drugs.